World-renowned centre of discovery science and translational research for diseases and injuries of the nervous system.
We aim to optimise and accelerate outcomes for people with severe disability by continuously striving to discover better treatments sooner. Our centre engages with the community to shape our research approach and to deliver solutions that make a difference to the quality of life of people with diseases and injuries of the nervous system.
The Centre is within the Institute for Biomedicine and Glycomics and is part of the School of Environment and Science and the School of Pharmacy and Medical Sciences.
The Clem Jones Foundation is the philanthropic arm of the Clem Jones Group. The trustees are dedicated to benefiting the community through ongoing commitments to the wishes and philosophies of the late Dr Clem Jones AO.
Our projects
Spinal Injury
This project is a translational research program developing an olfactory cell transplantation therapy for chronic and acute spinal cord injury.
Neurodegeneration
This project is investigating how pathogens can invade the brain and spinal cord via nerves within the nose, and the growing association between pathogens and neurodegeneration, particularly Alzheimer’s disease.
Peripheral Nerve Repair
This project is creating new three-dimensional (3D) cell transplantation options (nerve bridges) to repair peripheral nerve injuries.
Chief Investigators
A/Prof Jenny Ekberg
A/Prof Jenny Ekberg is a lead investigator of the Clem Jones Centre for Neurobiology and Stem Cell Research. She is a discovery research neuroscientist who determines the causes of injuries and diseases of the nervous system and explores novel approaches for therapy development.
Prof James St John
Professor James St John is Head of the Clem Jones Centre for Neurobiology and Stem Cell Research. He is a translational research neuroscientist who is developing cell transplantation and drug therapies to treat injuries and diseases of the nervous system.
Our Virtual Lab Tour
Contact Us
Latest news
World-first clinical trial for treating spinal cord injury
21 Oct 2024
A Phase I human clinical trial is set to commence to test the efficacy and safety of the...
$6.8 million grant for world-first Spinal Injury Project trial
12 Sep 2024
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord...
New views to restoring spinal function
11 Oct 2023
A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the...
Smell Clinic commences as researchers gather more data on Alzheimer’s disease
05 Sep 2023
A pilot smell clinic has commenced at Griffith’s Gold Coast campus in a bid to gather more data on...